• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Zyloware names James Shyer COO

Article

Long Island City, NY?Zyloware Corp. has named James Shyer to the newly created position of chief operating officer. In this role, Shyer will ensure that all divisions are operating in harmony with the company's overall vision and corporate strategy.

Executive additions

Long Island City, NY-Zyloware Corp. has named James Shyer to the newly created position of chief operating officer. In this role, Shyer will ensure that all divisions are operating in harmony with the company's overall vision and corporate strategy.

Derryberry joined Zyloware's sales division more than 4 years ago, previously serving as director of corporate accounts. Before joining Zyloware, she worked in marketing and sales with another eyewear frame company.

Related Videos
Katherine Talcott, MD, presenting slides
Katherine Talcott, MD, presenting slides
© 2024 MJH Life Sciences

All rights reserved.